ILLUMINA
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and ... prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.
ILLUMINA
Industry:
Biotechnology Genetics Health Care Medical
Founded:
1998-01-01
Status:
Active
Contact:
858.202.4500
Email Addresses:
[email protected]
Total Funding:
28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Apache
Similar Organizations
Aegis Sciences
A forensic toxicology and health care sciences laboratory.
ArmaGen Technologies
ArmaGen is focused on developing technologies for siRNA delivery across the blood-brain barrier.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Celixir
Celixir is a unique technology platform drives in-house discovery and manufacturing.
Crystalplex
Crystalplex provides fluorescent nanoparticle technology to the biomedical research, molecular diagnostic, and pathology markets.
Cynvec
Cynvec is a biotechnology company that develops a proprietary oncolytic technology for the treatment of cancer.
Genetic Technologies
Genetic Technologies is a molecular diagnostics company specializing in oncology.
Goodwin Biotechnology, Inc.
Goodwin Biotechnology is a biotechnology company that offers biologics process development and purification bioconjugation services.
Lasergen
Lasergen is a biotechnology company developing and commercializing technologies for genomic applications.
LifeWave
LifeWave focuses on developing non-invasive and sensing technology for prenatal and neonatal monitoring in clinical and remote settings.
Naviscan
Naviscan develops a high-resolution PET scanner that provides unprecedented visualization of small body parts.
NextCare
NextCare offers urgent care and occupational medical services for various illnesses such as cough, diaper rashes, earaches and more.
PolarityTE
PolarityTE is revolutionary platform induces cell and tissue polarity, creating uniquely functional tissue.
Ravgen
Ravgen is a biotechnology company that specializes in non-invasive prenatal diagnostic testing.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-06-28 | IDbyDNA | IDbyDNA acquired by Illumina | N/A |
| 2020-09-21 | Grail | Grail acquired by Illumina | 8 B USD |
| 2020-07-14 | Enancio | Enancio acquired by Illumina | N/A |
| 2020-06-17 | Bluebee | Bluebee acquired by Illumina | N/A |
| 2018-05-15 | Edico Genome | Edico Genome acquired by Illumina | 100 M USD |
| 2016-01-27 | Conexio Genomics | Conexio Genomics acquired by Illumina | N/A |
| 2015-08-04 | GenoLogics | GenoLogics acquired by Illumina | N/A |
| 2013-10-28 | NextBio | NextBio acquired by Illumina | N/A |
| 2013-07-23 | Advanced Liquid Logic | Advanced Liquid Logic acquired by Illumina | 96 M USD |
| 2013-01-08 | Moleculo | Moleculo acquired by Illumina | N/A |
Investors List
CW Group
CW Group investment in Venture Round - Illumina
Venrock
Venrock investment in Venture Round - Illumina
Lombard Odier
Lombard Odier investment in Venture Round - Illumina
Chevron Technology Ventures
Chevron Technology Ventures investment in Venture Round - Illumina
The Dow Chemical Company
The Dow Chemical Company investment in Venture Round - Illumina
Chase Capital Partners
Chase Capital Partners investment in Venture Round - Illumina
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - Illumina
Tredegar Investments
Tredegar Investments investment in Venture Round - Illumina
State Farm Insurance
State Farm Insurance investment in Venture Round - Illumina
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-07-27 | Mable (Neurolytic Healthcare) | Illumina investment in Pre Seed Round - Mable (Neurolytic Healthcare) | N/A |
| 2021-09-01 | SomaLogic | Illumina investment in Post-IPO Equity - SomaLogic | 375 M USD |
| 2021-04-01 | Concr | Illumina investment in Seed Round - Concr | 499.84 K GBP |
| 2020-05-28 | Ginkgo Bioworks | Illumina investment in Series F - Ginkgo Bioworks | 70 M USD |
| 2020-05-06 | Grail | Illumina investment in Series D - Grail | 390 M USD |
| 2018-03-01 | Helixis | Illumina investment in Venture Round - Helixis | 200 M USD |
| 2018-03-01 | Helix | Illumina investment in Series B - Helix | 200 M USD |
| 2016-11-15 | Prospect Bio | Illumina investment in Seed Round - Prospect Bio | 2.8 M USD |
| 2016-02-17 | Vitagene | Illumina investment in Seed Round - Vitagene | 2 M USD |
| 2016-01-12 | Grail | Illumina investment in Series A - Grail | 100 M USD |
Newest Events participated
Participated in Rock Health Summit
on 2015-09-29 as exhibitor